These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36723971)

  • 1. Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
    Larkin H
    JAMA; 2023 Feb; 329(7):531. PubMed ID: 36723971
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Mishra
    Krsak M; Harry BL; Palmer BE; Franco-Paredes C
    Viral Immunol; 2021 Nov; 34(9):659-660. PubMed ID: 34672802
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Vaccination and Previous Infection on Omicron Infections in Children.
    Lin DY; Gu Y; Xu Y; Zeng D; Wheeler B; Young H; Sunny SK; Moore Z
    N Engl J Med; 2022 Sep; 387(12):1141-1143. PubMed ID: 36069811
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
    Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
    Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(25):e100. PubMed ID: 34910868
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.
    Zheng H; Wu S; Chen W; Cai S; Zhan M; Chen C; Lin J; Xie Z; Ou J; Ye W
    Front Public Health; 2024; 12():1457266. PubMed ID: 39253287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components.
    Priyanka ; Choudhary OP; Singh I
    Travel Med Infect Dis; 2021; 39():101911. PubMed ID: 33186686
    [No Abstract]   [Full Text] [Related]  

  • 8. Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2022 Oct; 387(17):e50. PubMed ID: 36300981
    [No Abstract]   [Full Text] [Related]  

  • 9. Covid-19 vaccination: evidence of waning immunity is overstated.
    Scott J; Richterman A; Cevik M
    BMJ; 2021 Sep; 374():n2320. PubMed ID: 34556464
    [No Abstract]   [Full Text] [Related]  

  • 10. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.
    Jalkanen P; Kolehmainen P; Häkkinen HK; Huttunen M; Tähtinen PA; Lundberg R; Maljanen S; Reinholm A; Tauriainen S; Pakkanen SH; Levonen I; Nousiainen A; Miller T; Välimaa H; Ivaska L; Pasternack A; Naves R; Ritvos O; Österlund P; Kuivanen S; Smura T; Hepojoki J; Vapalahti O; Lempainen J; Kakkola L; Kantele A; Julkunen I
    Nat Commun; 2021 Jun; 12(1):3991. PubMed ID: 34183681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covid-19 vaccines: delivering protective immunity.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Dec; 371():m4838. PubMed ID: 33334862
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2 reinfection and implications for vaccine development.
    Nainu F; Abidin RS; Bahar MA; Frediansyah A; Emran TB; Rabaan AA; Dhama K; Harapan H
    Hum Vaccin Immunother; 2020 Dec; 16(12):3061-3073. PubMed ID: 33393854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added Benefit of Covid-19 Vaccination after Previous Infection.
    Klein NP
    N Engl J Med; 2022 Mar; 386(13):1278-1279. PubMed ID: 35353966
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
    Tenforde MW; Link-Gelles R; Patel MM
    JAMA; 2022 Oct; 328(14):1402-1404. PubMed ID: 36156638
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.
    Lim SH; Campbell N; Johnson M; Joseph-Pietras D; Collins GP; O'Callaghan A; Fox CP; Ahearne M; Johnson PWM; Goldblatt D; Davies AJ
    Lancet Haematol; 2021 Aug; 8(8):e542-e544. PubMed ID: 34224667
    [No Abstract]   [Full Text] [Related]  

  • 17. Protective immunity after recovery from SARS-CoV-2 infection.
    Kojima N; Klausner JD
    Lancet Infect Dis; 2022 Jan; 22(1):12-14. PubMed ID: 34762853
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations.
    Efrati S; Catalogna M; Abu Hamad R; Hadanny A; Bar-Chaim A; Benveniste-Levkovitz P; Levtzion-Korach O
    Sci Rep; 2021 Aug; 11(1):16543. PubMed ID: 34400714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.
    Katz MJ; Heaney CD; Pisanic N; Smith L; Bigelow BF; Sheikh F; Boudreau A; Kruczynski K; Hsu YJ; Salinas AB; Cosgrove SE; Rock C
    J Am Geriatr Soc; 2022 Mar; 70(3):659-668. PubMed ID: 35038344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.